MARKET

BNTX

BNTX

BIONTECH
NASDAQ

Real-time Quotes | Nasdaq Last Sale

118.68
-2.41
-1.99%
After Hours: 117.01 -1.67 -1.41% 18:05 12/03 EST
OPEN
119.85
PREV CLOSE
121.09
HIGH
121.80
LOW
115.00
VOLUME
4.22M
TURNOVER
--
52 WEEK HIGH
128.13
52 WEEK LOW
20.72
MARKET CAP
28.58B
P/E (TTM)
-124.5461
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Pfizer Stock Trips As Supply-Chain Issues Hamper Covid Vaccine Delivery
Pfizer stock tumbled Thursday after the company reportedly slashed its expectations for coronavirus vaccine deliveries in 2020 due to supply-chain issues.
Investor's Business Daily · 55m ago
'sure, Pfizer can say it is still on schedule, but we are now looking at a much more back-ended schedule. More sickness, more death...' -Tweet From Jim Cramer
https://twitter.com/jimcramer/status/1334616509612699655
Benzinga · 1h ago
Supply Chain Issues Cause Pfizer To Cut Initial COVID-19 Vaccine Shipments In Half
Pfizer (NYSE: PFE) shares fell after reports emerged the company expects to ship half of the COVID-19 vaccines it originally planned for this year due to supply-chain issues,
Benzinga · 1h ago
'Nov 9, when Pfizer reported its first phase 3 efficacy data, it included the new (reduced) forecast for supply...' -Tweet From CNBC's Meg Tirrell
https://twitter.com/megtirrell/status/1334607609903636488
Benzinga · 1h ago
Fauci walks back critical remarks of UK's authorization of Pfizer vaccine
"The U.K. has decided to do it a little bit differently, they've gone over it very quickly," Fauci had told Sky News earlier.
CNBC.com · 2h ago
Supply chain issues to restrict Pfizer COVID-19 shipments this month
Pfizer ([[PFE]] -2.1%) expects to ship only half of the COVID-19 vaccine doses this year that it originally planned due to supply chain obstacles, a near-term problem considering its ultra-cold
Seekingalpha · 2h ago
Inovio Strikes Coronavirus Vaccine Manufacturing Deal With Kaneka Unit
Inovio Pharmaceuticals Inc (NASDAQ: INO), which is developing a DNA vaccine against SARS-CoV-2, issued an update on its vaccine program Thursday, sending the stock high
Benzinga · 2h ago
Fauci Criticizes U.K. For Swift Approval Of Pfizer Vaccine
-Reuters
Reuters · 4h ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BNTX. Analyze the recent business situations of BIONTECH through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BNTX stock price target is 107.33 with a high estimate of 136.06 and a low estimate of 72.40.
EPS
Institutional Holdings
Institutions: 206
Institutional Holdings: 24.29M
% Owned: 10.09%
Shares Outstanding: 240.79M
TypeInstitutionsShares
Increased
48
4.49M
New
74
2.01M
Decreased
25
8.90M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BNTX
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of BioNTech SE - ADR stock information, including NASDAQ:BNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNTX stock methods without spending real money on the virtual paper trading platform.